Stroke and Vascular Neurology

Article	Citations
Dural sinus septum: an underlying cause of cerebral venous sinus stenting failure and complications	275
CerebrAlcare Pills on CereBral Small VesseL DiseasE (CABLE) trial: rationale and design	78
Photochemically induced thalamus infarction impairs cognition in a mouse model	58
Prediction of futile recanalisation after endovascular treatment in acute ischaemic stroke: development and validation of a hybrid machine learning model	47
Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospe	43
Multiomics genetic insights into potential molecular targets for intracranial aneurysm	38
Efficacy of immediate anti-hypertensive treatment in patients with acute ischaemic stroke stratified by mean arterial pressure and pulse pressure: a secondary analysis of the China Antihypertensive Tr	36
MetS in the prediction of asymptomatic intracranial arterial stenosis: the potential mediating role of hsCRP	35
Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease	34
Contact aspiration versus stent retriever thrombectomy for acute basilar artery occlusion (ANGEL-COAST): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint tr	34
Oxidised low-density lipoprotein and adverse outcome in patients with acute mild ischaemic stroke or high-risk TIA: a secondary analysis of the INSPIRES randomised clinical trial	27
Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry	27
Stepwise improvement in intracerebral haematoma expansion prediction with advanced imaging: a comprehensive comparison of existing scores	25
Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial	24
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial	24
Acute right insular ischaemic lesions and poststroke left ventricular dysfunction	23
Characteristics, temporal trends and outcomes of intravenous thrombolysis in Chinese patients aged>80 years who had a stroke	23
Tongxinluo capsule in the treatment of cerebral small vessel disease: protocol of a randomised, double-blind, placebo-controlled, multicentre clinical study (TOPS-CSVD)	22
Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort	22
KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway	22
Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy	22
Frequency, predictors and cardiovascular outcomes associated with transthoracic echocardiographic findings during acute ischaemic stroke hospitalisation	21
LRRC8A in endothelial cells contributes to the aberrant blood-brain barrier integrity in ischaemic stroke	20
Detailed phenotype of RNF213 p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack	20
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial	20

Endovascular treatment for basilar artery occlusion: a meta-analysis	19
Poststroke motor, cognitive and speech rehabilitation with brain–computer interface: a perspective review	18
Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus	18
Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study	18
Head-down position after reperfusion improves cerebral ischaemic injury in rat	18
Discontinuation of antiplatelet therapy after stent-assisted coil embolisation of cerebral aneurysm: a nationwide cohort study	17
Effect of haemodynamics on the risk of ischaemic stroke in patients with severe vertebral artery stenosis	16
CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats	16
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study	16
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study	16
Angioarchitecture and prognosis of pediatric intracranial pial arteriovenous fistula	16
STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke	15
Childhood strokes in China describing clinical characteristics, risk factors and performance indicators: a case-series study	15
Arteriolosclerosis differs from venular collagenosis in relation to cerebrovascular parenchymal damages: an autopsy-based study	15
Quantitative histopathological analysis of thrombi retrieved by mechanical thrombectomy and their association with stroke aetiology	14
Extracellular vesicles bearing serum amyloid A1 exacerbate neuroinflammation after intracerebral haemorrhage	14
Cerebrovascular cinematic rendering of multisystemic smooth muscle dysfunction syndrome	14
Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study	14
Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA	13
Dual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury	13
Central post-stroke pain: advances in clinical and preclinical research	13
Thrombolytic agents, more options, more challenges	13
Baseline systolic blood pressure and efficacy of dual antiplatelet in acute ischaemic stroke	13
Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial	13
Src inhibition rescues FUNDC1-mediated neuronal mitophagy in ischaemic stroke	13
Development, validation and comparison of multivariable risk scores for prediction of total stroke and stroke types in Chinese adults: a prospective study of 0.5 million adults	13
Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study	12
Incidence and predictors of futile recanalisation after endovascular therapy in acute vertebrobasilar artery occlusion patients: insight from the ANGEL-ACT registry	12
Retrograde recanalisation for vertebral artery stump syndrome: a case report	12
Sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections	12
Mobile stroke care expedites intravenous thrombolysis and endovascular thrombectomy	12
Rationale and design of Low-Frequency REpetitive TRanscranial Magnetic Stimulation Combined with Endovascular Treatment in ACute Ischaemic StrokE (RETRACE II): a randomised double-blind controlled mul	12
BEST-BAO: a multicentre, prospective, randomised controlled trial of endovascular treatment with or without intravenous thrombolysis in acute ischaemic stroke due to basilar artery occlusion – study p	11
Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study	11
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to impro	11
Loss of life expectancy due to stroke and its subtypes in urban and rural areas in China, 2005–2020	11
Brain-targeted extracellular vesicles for anti-cuproptosis therapy in subarachnoid haemorrhage	11
Secondary stroke evaluation in patients admitted for CRAO in a large national inpatient sample	11
Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion	11
Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study	11
Early blood pressure lowering and cerebral oedema in thrombolysis-treated stroke: secondary analysis of the ENCHANTED trial	10
Definitions of white matter hyperintensity change: impact on estimates of progression and regression	10
Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations	10
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications	10
Exosomes-mediated delivery of miR-486-3p alleviates neuroinflammation via SIRT2-mediated inhibition of mitophagy after subarachnoid hemorrhage	10
Outcomes of Onyx embolisation as primary treatment for intracranial dural arteriovenous fistulas over the past two decades	10
DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial	10
Exploring the relationship between embolic acute stroke distribution and supra-aortic vessel patency: key findings from an in vitro model study	10
Comparison of the Pipeline embolisation device alone or combined with coiling for treatment of different sizes of intracranial aneurysms	9
Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy	9

Young stroke in Bangladesh: addressing rare cases with diagnostic challenges and much-needed solutions	9
CSA declaration of next-generation reperfusion therapy for ischaemic stroke	9
Efficacy of butylphthalide in preventing cognitive decline in ischaemic stroke survivors: a 12-month prospective following-up study	9
Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry	9
Dl-3-n-butylphthalide attenuates brain injury caused by cortical infarction accompanied by cranial venous drainage disturbance	9
Cisternostomy for malignant middle cerebral artery infarction: proposed pathophysiological mechanisms and preliminary results	9
Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats	9
Incidence and prevalence of vascular cognitive impairment in China: a systematic review and meta-analysis	9
Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial	9
Neuronavigation-assisted stereotactic minimally invasive puncture with tenecteplase for the treatment of acute spontaneous deep intracerebral haemorrhage (NAS-TNK): rationale and design of a multicent	8
Associations of accelerated biological ageing with incident dementia, cognitive functions and brain structure: a prospective cohort study based on UK Biobank	8
Improving detection of cerebral small vessel disease aetiology in patients with isolated lobar intracerebral haemorrhage	8
Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases	8
Real-world analysis of two ischaemic stroke and TIA systolic blood pressure goals on 12-month mortality and recurrent vascular events	8
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-	8
COP27 climate change conference: urgent action needed for Africa and the world	8
Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)	8
Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneou	8
Intra-arterial thrombolytics during endovascular thrombectomy for acute ischaemic stroke in the MR CLEAN Registry	8
Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects	8
Why non-human primates are needed in stroke preclinical research	8
VasCog Screen test: sensitive in detecting cognitive impairment in patients who had a stroke or with heart failure	8
Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort study	7
Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial	7
PRCP is a promising drug target for intracranial aneurysm rupture supported via multi-omics analysis	7
Model based on single-nucleotide polymorphism to discriminate aspirin resistance patients	7
Haemorrhage after thrombectomy with adjuvant thrombolysis in unknown onset stroke depends on high early lesion water uptake	7
Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study	7
Application of bedside HINTS, ABCD2 score and truncal ataxia to differentiate cerebellar–brainstem stroke from vestibular neuritis in the emergency room	7
Rationale and design of a stepped wedge cluster randomised trial to improve acute reperfusion treatment quality for stroke: IMPROVE stroke care in China	7
Long-term outcome in a cohort of 36 patients with sacral dural arteriovenous fistulae after endovascular embolisation or microsurgery	7
Predictors of futile recanalisation in patients with large infarct: a post-hoc analysis of the ANGEL-ASPECT trial	7
Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update	7
Is intraprocedural intravenous aspirin safe for patients who require emergent extracranial stenting during mechanical thrombectomy?	7
Correlation of enlarged perivascular spaces in basal ganglion and cancer-associated stroke: a case–control study in China	7
Safety and Efficacy of Remote Ischaemic Conditioning for Acute Ischaemic Stroke Treated with Mechanical Thrombectomy (RECAST-MT): rationale and design	7
Microsurgical treatment of posterior inferior cerebellar aneurysms based on angioarchitecture supplemented by high-resolution vessel wall MRI: a case series report	6
Isolated anterior cerebral artery occlusion: an atypical form of moyamoya disease	6
Intra-arterial tenecteplase during thrombectomy for acute stroke (BRETIS-TNK II): rationale and design	6
Functional status at 30 and 90 days after mild ischaemic stroke	6
Risk factors for carotid plaque progression after optimising the risk factor treatment: substudy results of the Atherosclerotic Plaque Characteristics Associated with a Progression Rate of the Plaque	6
Clinical features, treatment and long-term outcomes of hemorrhagic moyamoya disease in children: an extensive follow-up study	6
Association between Life’s Essential 8 and Cerebral Small Vessel Disease	6
Clinical outcomes of endovascular interventions for cerebral venous thrombosis in Japan: a nationwide retrospective study	6
Multicentre prospective, randomised open-label, endpoint-blinded study to evaluate the safety and efficacy of propranolol for the prevention of stroke-associated pneumonia in patients with intracerebr	6
New rat model of spinal cord infarction with long-lasting functional disabilities generated by intraspinal injection of endothelin-1	6
Paediatric intracranial dural arteriovenous fistulas: clinical characteristics, treatment outcomes and prognosis	6
LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA	6
Thrombolysis of stroke mimics via telestroke	6
Dual versus mono antiplatelet therapy within 72 hours after onset for mild ischaemic stroke or transient ischaemic attack: meta-analysis of randomised controlled trials	6
In patients who had a stroke or TIA, enlarged perivascular spaces in basal ganglia may cause future haemorrhagic strokes	6
Distribution and prognosis of acute ischaemic stroke with negative diffusion-weighted imaging	5
Asymptomatic carotid artery stenosis is associated with increased Alzheimer’s disease and non-Alzheimer’s disease dementia risk	5
Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 2018	5
Bone marrow-derived mesenchymal stem cell ameliorates post-stroke enterobacterial translocation through liver-gut axis	5
Protective effects of melatonin on stroke in diabetic mice: central and peripheral inflammation modulation	5
0.23-Tesla MRI to differentiate between ischaemic and haemorrhagic strokes within 24 hours of onset: a combined experimental–clinical study	5
Roles of light transmission aggregometry and CYP2C19 genotype in predicting ischaemic complications during interventional therapy for intracranial aneurysms	5
Intracerebral haemorrhage laterality and associations with mood and pain: a MISTIE III substudy	5
Time to treat the climate and nature crisis as one indivisible global health emergency	5
Chinese Stroke Association guidelines on emergency stroke unit	5
Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial	5
Comparing the effectiveness and safety of rescue balloon angioplasty versus stenting in acute large vessel occlusion after thrombectomy	5
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke Tenecteplase II (CHABLIS-T II): rationale and design	5
Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography (PASS): rationale and design	5
Association of fluid balance with 3-month outcomes in severe acute ischaemic stroke	5
Should patients with minor strokes be given thrombolytics?	5
Residual inflammatory risk predicts long-term outcomes following stenting for symptomatic intracranial atherosclerotic stenosis	4
Pictures of stroke and cerebral vasculature: novel insights and detailed visualisation of U-shaped elastin distribution and disorganised fibre arrangement at carotid bifurcations by advanced technique	4
Characterising acute ischaemic stroke thrombi: insights from histology, imaging and emerging impedance-based technologies	4
Determinants of prehospital and in-hospital delay in patients with symptomatic carotid stenosis and their influence on the outcome after elective carotid endarterectomy	4
Vascular dementia has the highest hospitalisation rate in China: a nationwide hospital information system study	4
China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Dise	4
Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamics	4
Characteristics of brain structural damage related to cerebral small vessel disease in general population with intracranial artery stenosis	4
Comparing a novel Catfish flow restoration device and the Solitaire stent retriever for thrombectomy revascularisation in emergent largevessel occlusion stroke: a prospective randomised controlled stu	4
MALAT1 promotes platelet activity and thrombus formation through PI3k/Akt/GSK-3β signalling pathway	4
ADVISING score: a reliable grading scale based on injury and response for intracerebral haemorrhage	4
Magnitude of systolic blood pressure reduction following endovascular treatment and clinical outcomes in acute large artery occlusion stroke	4
Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOto	4

Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial	4
Predictors of malignant swelling in space-occupying cerebellar infarction	4
Anaesthesia modality on endovascular therapy outcomes in patients with large infarcts: a post hoc analysis of the ANGEL-ASPECT trial	4
Standardising the diagnosis and imaging of intracranial atherosclerotic stenosis in Asia: a call for regional consensus	4
Smoking status and the efficacy of remote ischaemic conditioning: a secondary analysis of the RICAMIS trial	4
Response to ‘comments on the article ‘sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections’’	4
Long-term functional outcomes improved with deep brain stimulation in patients with disorders of consciousness	4
Association of APOE genotype with CT markers of cerebral amyloid angiopathy in spontaneous intracerebral haemorrhage	3
Neglected Mendelian causes of stroke in adult Chinese patients who had an ischaemic stroke or transient ischaemic attack	3
White matter hyperintensity progression is associated with incident probable dementia or mild cognitive impairment	3
Efficacy and safety of a neurointerventional operation robotic assistance system in cerebral angiography	3
Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis (BASIS): protocol of a prospective, multicentre, randomised, controlled trial	3
Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)	3
Characteristics of intracranial plaque in patients with non-cardioembolic stroke and intracranial large vessel occlusion	3
Intelligent cholinergic white matter pathways algorithm based on U-net reflects cognitive impairment in patients with silent cerebrovascular disease	3
Where are we going for the treatment in ischaemic stroke: a comprehensive study of investigator-sponsored randomised controlled trials, 1990–2024	3
Stenting for symptomatic intracranial arterial stenosis with different qualifying arteries: a preplanned pooled individual patient data analysis	3
Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial	3
Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial	3
Prospective, multicentre study of screening, investigation and management of hyponatraemia after subarachnoid haemorrhage in the UK and Ireland	3
Endovascular thrombectomy with or without intravenous alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials	3
Antiplatelet therapy versus intravenous thrombolysis for mild acute ischaemic stroke: a living systematic review and meta-analysis	3
Altered excitability of motor neuron pathways after stroke: more than upper motor neuron impairments	3
Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya dis	3
Incidence and impact of brain lesions and cognitive impairment after CABG with moderate or severe cerebral artery stenosis seen on low-field MRI	3
Venous thromboembolism among Medicare acute ischaemic stroke patients with and without COVID-19	3
Association between elevated adiponectin levels and 5-year risk of clinical outcomes in patients with ischaemic stroke	3
Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials	3
Association of fluid-attenuated inversion recovery vascular hyperintensity with ischaemic events in internal carotid artery or middle cerebral artery occlusion	3
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial	3
When treating acute ischaemic stroke of LVO type, time window prevails over tissue window	3
Prestroke physical activity is associated with admission haematoma volume and the clinical outcome of intracerebral haemorrhage	3
Gut Microbiome and Stroke: a Bidirectional Mendelian Randomisation Study in East Asian and European Populations	3